Genomes and Genes
Summary: Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism.
Publications176 found, 100 shown here
- Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescentsHelmut Niederhofer
Christian Doppler Clinic, A 5020, Salzburg, Austria
Drug Alcohol Rev 22:295-7. 2003..In some cases, disulfiram may be an effective and well-tolerated pharmacological adjunct to psychosocial and behavioural treatment programmes for treatment of adolescent alcohol-dependent patients...
- The efficacy of disulfiram for the treatment of alcohol use disorderCharlotte H Jørgensen
WHO Collaborating Centre for Evidence Based Health Promotion in Hospitals and Health Services, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark
Alcohol Clin Exp Res 35:1749-58. 2011....
- Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivationBarbara J Mason
The Pearson Center for Alcoholism and Addiction Research and Molecular and Integrative Neurosciences Department, The Scripps Research Institute, 10550 North Torrey Pines Road, TPC 5, La Jolla, CA 92037, United States
J Psychiatr Res 40:383-93. 2006..The US study findings suggest that acamprosate is safe and well tolerated in a broadly inclusive sample of alcoholics and appears effective in populations of patients motivated to have a treatment goal of abstinence...
- Acamprosate and naltrexone treatment for alcohol dependence: an evidence-based risk-benefits assessmentBarbara J Mason
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA, USA
Eur Neuropsychopharmacol 13:469-75. 2003..The safety of the two drugs in combination has been supported by two independent double-blind studies, and combination treatment may offer an advantage for some patients...
- Does disulfiram have a role in alcoholism treatment today?Richard K Fuller
Addiction 99:21-4. 2004
- Medical treatment of alcohol dependence: a systematic reviewPeter M Miller
Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston, SC 29425, USA
Int J Psychiatry Med 42:227-66. 2011..To summarize published data on pharmacologic treatments for alcohol dependence alone and in combination with brief psychosocial therapies that may be feasible for primary care and specialty medical settings...
- Comparing topiramate with naltrexone in the treatment of alcohol dependenceDanilo Antonio Baltieri
Department of Psychiatry of the University of São Paulo, Brazil
Addiction 103:2035-44. 2008..To compare the efficacy of topiramate with naltrexone in the treatment of alcohol dependence...
- Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trialRaymond F Anton
Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston 29425, USA
JAMA 295:2003-17. 2006..Alcohol dependence treatment may include medications, behavioral therapies, or both. It is unknown how combining these treatments may impact their effectiveness, especially in the context of primary care and other nonspecialty settings...
- Medication treatment of different types of alcoholismBankole A Johnson
Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, 22908 0623, USA
Am J Psychiatry 167:630-9. 2010..Brief behavioral interventions that encourage the patient to set goals for a reduction in heavy drinking or abstinence also are part of optimal therapy...
- Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic reviewCarmen Bouza
Agency for Health Technology Assessment, Madrid, Spain
Addiction 99:811-28. 2004..To ascertain the efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence...
- The status of disulfiram: a half of a century laterJesse J Suh
Treatment Research Center, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA
J Clin Psychopharmacol 26:290-302. 2006..Preliminary evidence also suggests that disulfiram treatment could be a viable treatment for cocaine dependence because it was shown to reduce cocaine use among nonalcoholic, cocaine-dependent patients...
- Review of topiramate: an antiepileptic for the treatment of alcohol dependenceGeorge A Kenna
Department of Psychiatry and Human Behavior, Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02908, USA
Curr Drug Abuse Rev 2:135-42. 2009..While the manufacturer will not pursue approval of an indication for the treatment of alcohol dependence, the drug will soon be available generically, making it more affordable for a greater proportion of the public...
- Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trialFernando A Furieri
Vitória Municipal Addiction Treatment Center, Vitoria, Espirito Santo, Brazil
J Clin Psychiatry 68:1691-700. 2007..This study examined the efficacy of a 28-day gabapentin treatment in reducing alcohol consumption and craving...
- Combined therapy: what does acamprosate and naltrexone combination tell us?Falk Kiefer
Department of Psychiatry, University Hospital of Hamburg, Martinistrasse 52, 20246 Hamburg, Germany
Alcohol Alcohol 39:542-7. 2004..It remains to be answered whether data justify the combination of both drugs in clinical practice...
- Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistenceAlex H S Harris
Center for Health Care Evaluation, U S Department of Veterans Affairs VA Palo Alto Health Care System and Stanford University School of Medicine, 795 Willow Rd, 152 MPD, Menlo Park, CA 94025, USA
Psychiatr Serv 63:679-85. 2012..This study assessed changes since 2007 at Veterans Health Administration (VHA) facilities (N=129) in use of the medications approved by the U.S. Food and Drug Administration for treatment of alcohol use disorders...
- The effectiveness of continuing group psychotherapy for outpatients with alcohol dependence: 77-month outcomesJee Wook Kim
Department of Neuropsychiatry, Hangang Sacred Heart Hospital, Hallym University, Seoul, Korea
Alcohol Clin Exp Res 36:686-92. 2012..On that basis, a long-term comparative trial was performed with the main objective of evaluating the effectiveness of continuing group PT for outpatients with AD...
- Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylaseJason P Schroeder
Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA
Neuropsychopharmacology 35:2440-9. 2010..Our results suggest that disulfiram's efficacy in the treatment of cocaine addiction is associated with the inhibition of DBH and interference with the ability of environmental stimuli to trigger relapse...
- Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysisH R Kranzler
Alcohol Research Center, Department of Psychiatry, University of Connecticut School of Medicine, Farmington, Connecticut, USA
Alcohol Clin Exp Res 25:1335-41. 2001..In the absence of studies that compare the effects of these medications, we used a meta-analytic approach to the literature to compare their efficacy in alcoholism treatment...
- Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disordersIsmene L Petrakis
Department of Psychiatry, Yale University, New Haven, Connecticut 06516, USA
Biol Psychiatry 57:1128-37. 2005..Disulfiram and naltrexone are approved by the Food and Drug Administration (FDA) for the treatment of alcoholism, but these agents have not been rigorously evaluated in dually diagnosed individuals...
- Pharmacotherapy of alcohol dependence: a review of the clinical dataKarl Mann
Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany
CNS Drugs 18:485-504. 2004..Pharmacotherapy should be used in association with appropriate psychosocial support and specific treatment provided for any underlying psychiatric comorbidities...
- Pharmacological approaches to the management of alcohol addictionG Addolorato
Istituto di Medicina Interna, Universita Cattolica del Sacro Cuore, Roma
Eur Rev Med Pharmacol Sci 6:89-97. 2002..However, pharmacotherapy should not be considered as the only form of treatment but as an integrated part of a multimodal approach including psychological and social support...
- Disulfiram treatment for alcoholism in severe mental illnessKim T Mueser
Department of Psychiatry, Dartmouth Medical School, Concord, NH, USA
Am J Addict 12:242-52. 2003..The results suggest disulfiram may be a useful adjunctive treatment for alcoholism in patients with severe mental illness and that controlled research is needed to evaluate its effects in this population...
- New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependenceFalk Kiefer
University of Heidelberg, Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, CIMH, J5, D 68159 Mannheim, Germany
Eur J Pharmacol 526:163-71. 2005..New compounds are under investigation. This review discusses the neurobiological basis of alcohol addiction, pharmacological targets for relapse prevention treatment and pre-clinical and clinical results with the most promising drugs...
- A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependenceAlan de Sousa
Get Well Clinic and Nursing Home, 33rd Road, Off Linking Road, Bandra, Mumbai 400050, India
Alcohol Alcohol 39:528-31. 2004..To compare the efficacy of naltrexone and disulfiram in preventing an alcoholic relapse in routine clinical practice in an Indian metropolis...
- Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1George A Kenna
Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA
Am J Health Syst Pharm 61:2272-9. 2004..The neurobiological basis of alcohol dependence, established pharmacotherapies for alcohol dependence, pharmacotherapies under investigation, and obstacles to treatment are discussed...
- An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependenceAvinash De Sousa
Get Well Clinic and Nursing Home, 33rd Road, Off Linking Road, Bandra, Mumbai 400050, Maharashtra State, India
Alcohol Alcohol 40:545-8. 2005..To compare the efficacy of acamprosate (ACP) and disulfiram (DSF) for preventing alcoholic relapse in routine clinical practice...
- [Pharmacology of disulfiram - an update]J Mutschler
Klinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut fur Seelische Gesundheit, Mannheim
Fortschr Neurol Psychiatr 76:225-31. 2008..As an example we demonstrate a case, in which an acute neurological deficit was misjudged as a side effect of Disulfiram. Furthermore, the potential of Disulfiram as a promising treatment in addiction medicine will be discussed...
- Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatmentMárcia Fonsi Elbreder
Alcohol and Drugs Research Unit Uniad, Rua Botucatu 394 Vila Clementino CEP 04023 061, Sao Paulo SP, Brazil
Alcohol Alcohol 46:74-6. 2011..To identify factors associated with retention in treatment of alcohol-dependent individuals and to compare treatment retention between men and women...
- The use of disulfiram for alcohol-dependent patients and duration of outpatient treatmentMárcia Fonsi Elbreder
Department of Psychiatry, Federal University of Sao Paulo UNIFESP, Sao Paulo, Brazil
Eur Arch Psychiatry Clin Neurosci 260:191-5. 2010..Although disulfiram is an old medication, it seems that this drug can be useful for keeping alcohol-dependent patients under outpatient treatment...
- Paradigm to test a drug-induced aversion to ethanolE Garver
Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA
Alcohol Alcohol 35:435-8. 2000..This model should be of value in the testing of new agents that reduce aldehyde dehydrogenase levels for prolonged periods for their potential as an aversive treatment in alcoholism...
- [The role of the glutamatergic system in the pathogenesis and treatment of alcohol dependence]Karina Łukasik
Zakład Farmakodynamiki Uniwersytetu Medycznego w Łodzi, Łódź
Postepy Hig Med Dosw (Online) 64:534-43. 2010..There are promising preclinical results of groups I and II metabotropic receptor antagonists. However, further studies are necessary to elucidate precisely their role in alcohol dependence...
- Supervised disulfiram as adjunct to psychotherapy in alcoholism treatmentHenning Krampe
Department of Anaesthesiology and Intensive Care Medicine, Charite Universitatsmedizin Berlin, Germany
Curr Pharm Des 16:2076-90. 2010....
- Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patientsL Annemans
Vrije Universiteit Brussel, Brussels, Belgium
Eur Addict Res 6:71-8. 2000..A global anticipated net saving of 70 million BEF (1.74 million Euro) over 2 years was estimated for the Belgian health insurance...
- New pharmacotherapies for alcohol dependenceRobert Graham
St Vincent s Hospital, Sydney, NSW, Australia
Med J Aust 177:103-7. 2002..Adjunctive psychosocial treatment with close follow-up is required for acamprosate and recommended for naltrexone. As yet, no studies have reported a reduction in mortality following the use of any pharmacotherapy for alcohol dependence...
- Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patientsAlexander Diehl
Department of Psychiatry, Klinikum Braunschweig, Braunschweig, Germany
Alcohol Alcohol 45:271-7. 2010..To compare the long-term effectiveness of acamprosate (ACP) and disulfiram (DSF) in the treatment of alcohol dependence and their effectiveness in regard to patient characteristics, within a naturalistic outpatient treatment setting...
- Disulfiram impairs the development of behavioural sensitization to the stimulant effect of ethanolAndrezza Kyunmi Kim
Departamento de Psicobiologia Universidade Federal de São Paulo UNIFESP, Rua Napoleao de Barros 925, Sao Paulo, Sao Paulo, Brazil
Behav Brain Res 207:441-6. 2010..This study sought to analyze the influence of disulfiram on the development of behavioural sensitization to the stimulant effect of ethanol...
- Safety issues concerning the use of disulfiram in treating alcohol dependenceJ Chick
Department of Psychiatry, University of Edinburgh, Scotland
Drug Saf 20:427-35. 1999..Disulfiram can be viewed as a drug with a moderate record of adverse effects. Alcohol dependence, for which it can be a helpful treatment, is associated with a high morbidity and mortality...
- Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled studyKee Namkoong
Department of Psychiatry, Yonsei University College of Medicine, Seoul, South Korea
Alcohol Alcohol 38:135-41. 2003..A multi-centre, randomized, double-blind, placebo-controlled trial was conducted to evaluate the efficacy and the safety of acamprosate over 8 weeks in Korean alcohol-dependent patients...
- Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patientsRoel Verheul
Department of Clinical Psychology, University of Amsterdam, Amsterdam, The Netherlands
Psychopharmacology (Berl) 178:167-73. 2005..However, acamprosate prevents lapses or relapses only in a minority of patients. An important question, therefore, is whether there is a specific subgroup of patients who respond particularly well to acamprosate...
- Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependenceGabriel Rubio
Dual Diagnoses Unit, Department of Psychiatry, Hospital Universitario 12 de Octubre, Madrid, Spain
J Clin Psychopharmacol 29:584-9. 2009..The results of this study indicate that TP reduces drinking and that the mechanisms underlying this effect may involve, at least in part, modulation of the behavioral inhibition paradigm...
- Pharmacotherapy of alcohol use disorders in the Veterans Health AdministrationAlex H S Harris
Center for Health Care Evaluation, Department of Veterans Affairs Palo Alto Health Care System, 795 Willow Rd MC152, Menlo Park, CA 94025, USA
Psychiatr Serv 61:392-8. 2010..Their availability and consideration of their use in treatment are now standards of high-quality care. This study determined rates of medication initiation among Veterans Health Administration (VHA) patients...
- Combining psychosocial treatment with pharmacotherapy for alcohol dependenceRoger D Weiss
Alcohol and Drug Abuse Treatment Program, McLean Hospital, Belmont, MA 02478, USA
J Clin Psychopharmacol 26:S37-42. 2006..Ongoing research examining the optimal combinations of medications with different psychosocial treatments for alcohol dependence may further inform the field...
- Treatment of alcohol-dependent outpatients with acamprosate: a clinical reviewB J Mason
Department of Psychiatry and Behavioral Sciences, University of Miami/JMH Medical Center, Fla 33136, USA
J Clin Psychiatry 62:42-8. 2001..The drug's reliable effect on prolonging abstinence, in conjunction with an excellent safety profile, suggests that acamprosate may be useful for a broad range of patients with alcohol dependence...
- A critical review of pharmacoeconomic studies of acamprosateFlavio Poldrugo
Office for Research and Innovative Projects on Alcohol, Other Addictions and Mental Health, Department of Psychiatry, University of Trieste, Via De Pastrovich 5 A, 34126 TRIESTE, Italy
Alcohol Alcohol 40:422-30. 2005..This review assessed the published data on the cost-effectiveness of acamprosate for the treatment of alcohol dependence...
- Interest in pharmacotherapy and primary care alcoholism treatment among medically hospitalized, alcohol dependent patientsScott H Stewart
Psychiatry and Medicine, Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston, SC 29425, USA
J Addict Dis 26:63-9. 2007..Medically hospitalized patients with alcohol dependence were interested in effective medication for relapse prevention, but primary care follow-up alone may not adequately address patients' perceived treatment needs...
- Medications for treating alcohol dependenceSteven H Williams
Psychology Service, Veterans Affairs Medical Center, Lebanon, Pennsylvania 17042, USA
Am Fam Physician 72:1775-80. 2005..S. Food and Drug Administration for this indication, the anticonvulsant topiramate and several serotonergic agents (e.g., fluoxetine, ondansetron) have been shown in recent studies to increase abstinence rates and decrease drinking...
- Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcomeHenning Krampe
Department of Psychiatry and Psychotherapy, Georg August University, and Max Planck Institute of Experimental Medicine, Goettingen, Germany
Alcohol Clin Exp Res 30:86-95. 2006..patients, participants of the Outpatient Longterm Intensive Therapy for Alcoholics (OLITA); (2) To investigate the role of supervised alcohol deterrents (AD) in relapse prevention and as an adjunct for maintenance of long-term abstinence.
- Metadoxine in the treatment of acute and chronic alcoholism: a reviewG Addolorato
Institute of Internal Medicine, Catholic University of Rome, Italy
Int J Immunopathol Pharmacol 16:207-14. 2003..In this review the preclinical and clinical results obtained using metadoxine in acute and chronic alcohol intoxication are reported...
- Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled studyLeonid S Shpilenya
Narcological County Dispensary, Vasyleostrovsky District 4 th, Line V 0 2 3 2 5, St Petersburg, Russia
Alcohol Clin Exp Res 26:340-6. 2002..The present study was planned with the aim of investigating the effectiveness of metadoxine in the management of patients affected by acute ethanol intoxication...
- Use of pharmacotherapies for the management of addictive behaviours in Australian clinical practiceChristopher M Doran
School of Population Health, School of Economics, University of Queensland, Mayne Medical Building, Herston Road, Herston QLD 4006, Australia
Addict Behav 31:1947-58. 2006..To collect data on the behaviours associated with the prescription of pharmacotherapies (bupropion, acamprosate and naltrexone) for nicotine and alcohol dependence in Australian clinical practice...
- Pharmacotherapy for alcohol dependence: anticraving medications for relapse preventionYoung Chul Jung
Department of Psychiatry, Yonsei University College of Medicine, 134 Shinchon dong, Seodaemun gu, Seoul 120 752, Korea
Yonsei Med J 47:167-78. 2006..In addition, novel medications are being investigated to assess their efficacy in preventing relapse and increasing abstinence...
- Pharmacological treatment of alcohol dependence: target symptoms and target mechanismsMarkus Heilig
National Institute on Alcohol Abuse and Alcoholism NIH DHHS, 10 Center Drive, 10 1E 5334 Bethesda, MD 20892 1610, United States
Pharmacol Ther 111:855-76. 2006..Once novel treatments are developed, the field faces a major challenge to assure their delivery to patients...
- Naltrexone and disulfiram in patients with alcohol dependence and current depressionIsmene Petrakis
Department of Psychiatry, Yale University School of Medicine, Veterans Affairs Connecticut Healthcare System, West Haven Campus, West Haven, CT 06516, USA
J Clin Psychopharmacol 27:160-5. 2007..In particular, the effect of these medications on alcohol use outcomes and on specific psychiatric symptoms is still unknown in patients with the most common co-occurring disorder, major depression...
- Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?Falk Kiefer
Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany
Biol Psychiatry 60:74-6. 2006..We examined the relationship between efficacy of pharmacological anticraving treatment and HPA axis activity in the relapse prevention treatment of alcoholism...
- Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapyGerald F X Feeney
Alcohol and Drug Assessment Unit, Princess Alexandra Hospital, Brisbane, Queensland 4102, Australia
Alcohol Alcohol 41:321-7. 2006..To compare treatment outcomes amongst patients offered pharmacotherapy with either naltrexone or acamprosate used singly or in combination, in a 12-week outpatient cognitive behavioural therapy (CBT) programme for alcohol dependence...
- Alcoholism and suicidal behavior: a clinical overviewL Sher
Division of Neuroscience, Department of Psychiatry, Columbia University, New York, NY 10032, USA
Acta Psychiatr Scand 113:13-22. 2006..The purpose of this paper was to provide a clinical review of the literature on the relation of alcoholism to suicidal behavior...
- Pharmacotherapy of alcohol use disordersAlessandra Buonopane
Department of Psychiatry, School of Medicine, Yale University, New Haven, Connecticut, USA
Subst Use Misuse 40:2001-20, 2043-8. 2005..An overview of the serotonergic agents is also provided. Finally, future directions, including new medications and some clinical strategies that show promise but are not yet used extensively clinically, are mentioned...
- Trends in the adoption of medications for alcohol dependenceLori J Ducharme
Institute for Behavioral Research, University of Georgia, Athens, GA 30602 2401, USA
J Clin Psychopharmacol 26:S13-9. 2006..Preliminary data suggest that the early adoption of acamprosate is following a similar pattern. Recommendations for addressing challenges to the diffusion of pharmacotherapies for alcohol dependence are presented...
- The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disordersAron N Starosta
University of Pennsylvania, PA 19104, USA
J Psychiatr Pract 12:80-9. 2006..This paper describes these components and discusses how the empirical support for each component is linked to the enhancement of medication compliance and the improvement of treatment outcomes...
- [Maintaining abstinence after alcohol detoxification]Philippe Batel
Traitement ambulatoire des maladies de l alcool, Hopital Beaujon, Clichy
Rev Prat 56:1100-6. 2006....
- Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in SwitzerlandCaroline Buri
University Hospital of Psychiatry Bern, Bolligenstrasse 111, 3000 Bern 60, Switzerland
Alcohol Alcohol 42:333-9. 2007..There remains, however, a paucity of studies with sufficient external validity in which the effectiveness of pharmacotherapy in clinical practice is investigated. This study aimed to make a contribution to close this gap in research...
- Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokersLutz G Schmidt
Department of Psychiatry, Johannes Gutenberg University Mainz, Untere Zahlbacher Str 8, 55131 Mainz, Germany
Alcohol Alcohol 42:241-6. 2007..To assess the role of smoking on treatment outcome in quitting alcoholics on the background of the priming or coping hypothesis (Rohsenow et al., 1997)...
- The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: a relative benefits analysis of randomized controlled trialsJames L Snyder
Penn State Harrisburg, Middletown, Pennsylvania 17057, USA
Am J Drug Alcohol Abuse 34:449-61. 2008..There was insufficient data available to ascertain the efficacy of naltrexone and acamprosate over prolonged periods of time, or the effectiveness of the medications relative to each other...
- Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexoneFalk Kiefer
Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Germany
Addict Biol 13:124-9. 2008..It is discussed whether especially these subjects should be targeted for pharmacological relapse prevention treatment with naltrexone...
- New therapies for alcohol dependence open options for office-based treatmentBridget M Kuehn
JAMA 298:2467-8. 2007
- Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomesSusanne Rösner
IFT, Institut für Therapieforschung, Munich, Germany
J Psychopharmacol 22:11-23. 2008..Benefits in the treatment of alcohol dependence might be optimized by matching the efficacy profiles of specific antidipsotropics with the motivational status of alcohol-dependent patients...
- [Alcohol dependence: diagnosis and treatment]P Perney
Service d Addictologie, CHU Caremeau, 30029 Nimes Cedex 9, France
Rev Med Interne 29:297-304. 2008..5 million patients in France. A review about alcohol dependence is warranted, not only as prevalence of this disease is high, but also because of recent significant improvement in caring for these patients...
- From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gapChristopher W Shea
Fr Martin s Ashley, Havre de Grace, Maryland 21078, USA
South Med J 101:179-85. 2008..Pharmacotherapy represents a valuable component of treatment and should be combined with psychosocial and behavioral interventions to address the multifactorial nature of AD in individuals with this disease...
- The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholicsWendy Ooteman
Amsterdam Institute for Addiction Research, Amsterdam, The Netherlands
Eur Neuropsychopharmacol 17:558-66. 2007..It is hypothesized that naltrexone exerts its effects primarily on cue-induced craving and neuroendocrine cue reactivity, whereas acamprosate exerts its effect primarily on autonomic nervous system reactions to alcohol-related cues...
- Preclinical and clinical pharmacology of alcohol dependenceSophie Tambour
Unité de Recherche en Psychologie Expérimentale et Neurosciences Cognitives URPENC, Universite de Liege, Boulevard du Rectorat 5 B32, B 4000 Liege, Belgium
Fundam Clin Pharmacol 21:9-28. 2007..These new drugs in the field of alcohol pharmacotherapy are also discussed, together with their mechanisms of action...
- Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionstFelice Nava
Department of Addiction Medicine, Drug Abuse Unit Ser T, Hospital of Castelfranco Veneto, Via Ospedale, 18, 31033 Castelfranco Veneto Treviso, Italy
J Psychoactive Drugs 38:211-7. 2006..The maximum effects were observed in GHB-treated patients. The results of the present study suggest that GHB might act both as anticraving and cellular protector agent...
- Choosing the right medication for the treatment of alcoholismHelen M Pettinati
Department of Psychiatry, University of Pennsylvania, Treatment Research Center, 3900 Chestnut Street, Philadelphia, PA 19104 6178, USA
Curr Psychiatry Rep 8:383-8. 2006..This report reviews the latest innovations in pharmacotherapy for the treatment of alcohol dependence, focusing on FDA-approved medications presently available to the treatment community...
- Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?Kylie Richardson
Central Clinical School of Medicine, University of Sydney, NSW, Australia
Addiction 103:953-9. 2008..To explore the effect of acamprosate and naltrexone on craving and alcohol consumption in the treatment of alcohol dependence...
- Extended-release intramuscular naltrexone: a viewpoint by Henry R KranzlerHenry R Kranzler
University of Connecticut School of Medicine, Farmington, CT, USA
Drugs 66:1753-4. 2006
- Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorderIsmene L Petrakis
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516, USA
Biol Psychiatry 60:777-83. 2006....
- Which treatment for alcohol dependence: naltrexone, acamprosate and/or behavioural intervention?Sheila A Doggrell
School of Science, Faculty of Education, Health and Science, Charles Darwin University, Darwin, Northern Territory 0909, Australia
Expert Opin Pharmacother 7:2169-73. 2006..In COMBINE, this percentage was high in the group having medical management and placebo pills, and naltrexone or additional behavioural therapy only had modest additional effects...
- [Neurobiological mechanisms and pharmacological treatment options for alcohol craving]T Hillemacher
Psychiatrische und Psychotherapeutische Klinik, Universitatsklinikum Erlangen, Germany
Fortschr Neurol Psychiatr 75:26-32. 2007..Besides, there are several promising candidate substances. Current investigations focus on a differentiated pharmacotherapy of alcohol dependence, including psychological and genetic factors...
- New pharmacological approaches for the treatment of alcoholismMichael Soyka
Private Hospital Meiringen, P O Box 612, CH 3860 Meiringen, Switzerland
Expert Opin Pharmacother 7:2341-53. 2006..Tricyclics have been found to be more effective than serotonin reuptake inhibitors in improving depressive symptoms in these patients...
- [Pharmacological relapse prevention in alcohol and tobacco dependence]A Diehl
Klinik für Abhängiges Verhalten und Suchtmedizin, Zentralinstitut fur Seelische Gesundheit, J5, 68159, Mannheim, Germany
Internist (Berl) 48:79-84, 86-8. 2007..A specific application of these substances will optimise the outcome for alcohol and tobacco dependent patients...
- [Pharmacological review of alcoholic dependence treatment]Leandro Oural
Vertex 19:512-21. 2008..We will also refer to topiramate, which is being studied for this indication...
- Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in IndiaDebasish Basu
Drug De addiction and Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Am J Addict 14:381-95. 2005..Logistic regression analysis showed that both family/social support and acamprosate appeared to contribute modestly toward explaining the variance in short-term outcome...
- Addiction medicine for the primary care physicianW H Yarborough
University of Oklahoma, College of Medicine, Tulsa Campus, Department of Internal Medicine, 4502 E. 41st Street, Tulsa, OK 74135-2512, USA
J Okla State Med Assoc 94:499-506. 2001..Finally a look at parity for addiction treatment with a discussion of the cost and the benefits to society are also outlined...
- A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexoneBarbara J Mason
Division of Substance Abuse, Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, FL, USA
Neuropsychopharmacology 27:596-606. 2002..A complete absence of negative interactions on measures of safety and cognitive function supports the absence of a contraindication to co-administration of acamprosate and naltrexone in clinical practice...
- Recent advances in the pharmacotherapy of alcoholismHugh Myrick
Alcohol Research Center, Medical University of South Carolina Department of Psychiatry and Behavioral Sciences, 67 President Street, Charleston, SC 29425, USA
Curr Psychiatry Rep 6:332-8. 2004..Data on naltrexone, acamprosate, and topiramate will be highlighted. In addition, data concerning the use of serotonin reuptake inhibitors in subtypes of alcoholism and the use of combination pharmacotherapy will be reviewed...
- Physicians' opinions about medications to treat alcoholismTami L Mark
Medstat, Washington, DC 20008, USA
Addiction 98:617-26. 2003..This paper examines physicians' opinions about and use of two alcoholism medications currently approved in the US--disulfiram and naltrexone--and one alcoholism medication--acamprosate--that might be approved...
- [Long-term treatment of alcohol dependance]Louis Philippe Fideli
Psychiatrie, CHU Louis Mourier, 178, rue des Renouillers, 92700 Colombes, France
Gastroenterol Clin Biol 26:B169-73. 2002
- Learning the language of abstinence in addiction treatment: some similarities between relapse-prevention with disulfiram, naltrexone, and other pharmacological antagonists and intensive "immersion" methods of foreign language teachingColin Brewer
The Stapleford Centre, London, United Kingdom
Subst Abus 24:157-73. 2003..Supervised or depot naltrexone acts similarly in opiate dependence. We discuss the concept of antagonist-assisted abstinence...
- Effect of the combination of naltrexone and acamprosate on alcohol intake in miceSung Gon Kim
Department of Psychiatry, School of Medicine, Pusan National University, Pusan, Korea
Psychiatry Clin Neurosci 58:30-6. 2004..When combined with naltrexone, acamprosate reduced alcohol consumption across both doses of naltrexone. This effect was sensitive to both dose and number of days of exposure to the naltrexone/acamprosate combination...
- [Drug therapy of alcohol dependence--a critical review]Mikko Salaspuro
Biomedicum Helsinki, Päihdelääketieteen tutkimusyksikkö PL 63, 00014 Helsingin yliopisto
Duodecim 119:2503-7. 2003
- Use of acamprosate and opioid antagonists in the treatment of alcohol dependence: a European perspectiveMichael Soyka
Psychiatric Hospital, University of Munich, Munich, Germany
Am J Addict 12:S69-80. 2003..Some centers suggest naltrexone not only for patients aiming for abstinence but also for patients for whom continued drinking is a therapeutic possibility or a clinical inevitability...
- AcamprosateBarbara J Mason
Department of Psychiatry and Behavioral Sciences, University of Miami School of Medicine, Miami, Florida 33136, USA
Recent Dev Alcohol 16:203-15. 2003
- [The pharmacologic treatment of the alcohol dependence]Luís André Castro
Unidade de Pesquisa Clínica, Unidade de Pesquisa em Alcool e Drogas, Departamento de Psiquiatria, EMP UNIFESP, Brazil
Rev Bras Psiquiatr 26:S43-6. 2004..Ondansetron, has shown promise in the early-onset alcohol dependence but needs more extensive study. Topiramate (up to 300 mg per day) was more efficacious than placebo in the treatment of alcohol dependence...
- Pharmacologic approaches to the management of alcoholismR F Anton
Alcohol Research Center, Medical University of South Carolina, Charleston 29425, USA
J Clin Psychiatry 62:11-7. 2001..This article will discuss animal and clinical studies of the opioid antagonists (primarily naltrexone), acamprosate, and disulfiram. The side effects and treatment recommendations for each drug will also be reviewed...
- Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependenceJohn Littleton
Department of Molecular and Biomedical Pharmacology, University of Kentucky, Lexington, KY 40546 0236, USA
Am J Addict 12:S3-11. 2003....
- Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trialsJ A Boening
Department of Psychiatry, Addiction Medicine, University of Wuerzburg, Germany
Alcohol Clin Exp Res 25:127S-131S. 2001..Wiesbeck; and (6) Methodology and behavioral therapy of the U.S. acamprosate study, by Barbara J. Mason...
- Increasing leptin precedes craving and relapse during pharmacological abstinence maintenance treatment of alcoholismFalk Kiefer
Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health CIMH, University of Heidelberg, J5, 68159 Mannheim, Germany
J Psychiatr Res 39:545-51. 2005..Moreover, there are hints for an interaction between pharmacological anti-craving treatment, plasma concentration of leptin, and abstinence duration...
- Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatmentG Rubio
Psychiatric Service, 12 de Octubre University Hospital, Madrid, Spain
Alcohol Alcohol 36:419-25. 2001..There were non-significant trends for the naltrexone group to comply better with medication, to stay in the study longer, and to show greater improvement over baseline in serum GGT...
- One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatmentK M Carroll
Department of Psychiatry, Yale University School of Medicine, USA
Addiction 95:1335-49. 2000..To evaluate outcomes 1 year after cessation of treatment for cocaine- and alcohol-dependent individuals...
- Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomideJoanna Triscott
Department of Pediatrics, University of British Columbia, Vancouver, BC
Oncotarget 3:1112-23. 2012..Likewise, PLK1 inhibition with siRNA, or small molecules (BI-2536 or BI-6727) blocked growth of TMZ resistant cells. Our studies suggest that DSF has the potential to be repurposed for treatment of refractory GBM...
- Monitoring relapse drinking during disulfiram therapy by assay of urinary 5-hydroxytryptopholA Helander
Karolinska Institute, Department of Clinical Neuroscience, St Gorans Hospital, Stockholm, Sweden
Alcohol Clin Exp Res 22:111-4. 1998..It is also suggested that an individual dose-titration regimen, whereby the disulfiram dose is raised gradually until 5HTOL/5HIAA testing indicates sobriety, will improve therapeutic effectiveness...
- Preliminary findings on the use of metadoxine for the treatment of alcohol dependence and alcoholic liver diseaseLorenzo Leggio
Center for Alcohol and Addiction Studies, Brown University, Providence, Rhode Island 02912, USA
Hum Psychopharmacol 26:554-9. 2011..Metadoxine is approved in Europe for alcohol intoxication and is also indicated for alcoholic liver disease (ALD). This study aims to investigate the use of metadoxine as a potential pharmacotherapy for alcohol dependence (AD)...
- Maximizing CBT's Efficacy with Medication & CMKathleen Carroll; Fiscal Year: 2009..Variables assessing theoretical mechanisms of action will be assessed monthly during treatment. ..
- Planning for a CTSA Application at the University of ConnecticutJudith Fifield; Fiscal Year: 2006..unreadable] [unreadable] [unreadable]..
- Matching 5-HT Genotypes to Serotonergic Medications for AlcoholismGEORGE ANTHONY KENNA; Fiscal Year: 2010....
- Sertraline Pharmacotherapy for Alcoholism SubtypesHenry Kranzler; Fiscal Year: 2007..abstract_text> ..
- GENETICS OF COCAINE DEPENDENCEHENRY RICHARD KRANZLER; Fiscal Year: 2010..Knowledge of the gene variants will help to identify people at greatest risk of developing the disorder, thereby improving prevention efforts. ..
- CANNABIS AND SCHIZOPHRENIA: CLOZAPINE VS RISPERIDONEAlan Green; Fiscal Year: 2005..If the results of this study confirm the preliminary data, they could suggest a new use for CLOZ, one that could have important public health implications. ..
- Efficacy and Safety of Baclofen for Alcohol DependenceJames Garbutt; Fiscal Year: 2006..Several studies also have found that baclofen reduces self-reported anxiety and craving; thus, the proposed study will assess baclofen's ability to reduce these symptoms as well. ..
- BEHAVIORAL SUPPORT WITH PHARMACOTHERAPY FOR ALCOHOLICSHelen Pettinati; Fiscal Year: 2004..However, each study site has provided site-specific information on the budget, budget justifications, listing of key personnel, consultant/consortium agreements, and human subjects sections of their respective proposals. ..
- Clozapine, cannabis and first episode schizophreniaAlan Green; Fiscal Year: 2003....
- Modifying Group Therapy for Bipolar AbusersRoger Weiss; Fiscal Year: 2006..If warranted by the results, effect sizes from the proposed study will be used to help in the preparation of a larger-scale subsequent Stage II study. ..
- Gabapentin as an Adjunct to Naltrexone for AlcoholismRaymond Anton; Fiscal Year: 2006..This evaluation of a novel treatment will allow us to better understand combined pharmacotherapy and develop a new paradigm for medications development for alcoholism. ..
- POLYDRUG ABUSE-IMAGING AND BEHAVIORScott Lukas; Fiscal Year: 2006..Results of these studies may also reveal why cue-induced craving has not been a good predictor of relapse as there may be significant cross generalization among the cues that can trigger relapse in successfully treated patients. ..
- ALCOHOLISM AND SCHIZOPHRENIA--EFFECTS OF CLOZAPINEAlan Green; Fiscal Year: 2001....
- Cocaine Withdrawal and Pharmacotherapy ResponseMehmet Sofuoglu; Fiscal Year: 2010..This proposal, by testing the efficacy of carvedilol and investigating the influence of withdrawal severity on carvedilol's efficacy, may result in development of more effective treatments for cocaine addiction. ..
- PHARMACOLOGICAL AND BEHAVIORAL INDICES OF DRUG ABUSEScott Lukas; Fiscal Year: 2008..abstract_text> ..
- Topiramate for alcohol and cocaine dependenceKyle Kampman; Fiscal Year: 2008..abstract_text> ..
- Cannabis Dependence: Imaging and Medication DevelopmentScott Lukas; Fiscal Year: 2005..abstract_text> ..
- MEDICATION DEVELOPMENT FOR COCAINE ABUSE--CDP CHOLINEScott Lukas; Fiscal Year: 2004....
- Cannabis and Schizophrenia: Self-Medication and Agonist Treatment?Alan I Green; Fiscal Year: 2010..Finding medications that may be able to limit cannabis use and thereby reduce adverse outcomes in patients with schizophrenia is of great public health importance. ..
- RELAPSE PREVENTION GROUP FOR BIPOLAR SUBSTANCE ABUSERSRoger Weiss; Fiscal Year: 2001....
- Cannabis & Schizophrenia: fMRI Reward Circuit BiomakerAlan Green; Fiscal Year: 2005..Finding new medications, safer than CLOZ, that may be able to limit cannabis use In patients with SCHIZ is thus of considerable public health relevance. ..
- Three Methods for Costing Methadone Treatment ServicesGARY ZARKIN; Fiscal Year: 2006..abstract_text> ..
- SERTRALINE FOR ALCOHOL DEPENDENCE AND DEPRESSIONHelen Pettinati; Fiscal Year: 2003..Overall, this project will determine if combining pharmacotherapies results in a better response in comorbidly depressed alcoholics than either medication alone or placebo. ..
- Antipsychotics and Alcohol Drinking in RodentsAlan Green; Fiscal Year: 2005..The long-term goal of our research is to create better treatments for alcoholism in patients with SCH (and possibly even in those without SCH). ..
- TRAINING IN FUNCTIONAL IMAGING AND ALCOHOL WITHDRAWALDONALD MYRICK; Fiscal Year: 2004....
- COST EFFECTIVENESS OF ALCOHOL TREATMENTGARY ZARKIN; Fiscal Year: 2004..abstract_text> ..
- Modeling Benefits and Costs of Prison-Based Substance Abuse TreatmentGARY ZARKIN; Fiscal Year: 2009..2005a). Results will help policy makers make better judgments about the allocation of funding to prison-based drug treatment resources. ..
- GABA Medications for Tobacco AddictionMehmet Sofuoglu; Fiscal Year: 2009..The findings of this study will provide valuable information to develop new pharmacotherapies for smoking cessation. ..
- Progestrone and the Effects of NicotineMehmet Sofuoglu; Fiscal Year: 2006..By characterizing the progesterone effects on nicotine dependence, this study may provide a better understanding of the mechanisms which mediate the sex and menstrual cycle phase effects on nicotine dependence. ..
- LEAD: ATTENTION, IMPULSIVITY, AND DOPAMINESTEPHEN KIEFER; Fiscal Year: 2002..abstract_text> ..
- Alcohol Dependence in General Medical SettingsScott Stewart; Fiscal Year: 2008....
- AMLODIPINE TREATMENT FOR COCAINE DEPENDENCERobert Malcolm; Fiscal Year: 2001....
- Alcohol Screening and Brief Intervention in an EAPJeremy Bray; Fiscal Year: 2008..Taken together, our findings will provide researchers, EAP professionals, employers, and policy makers with a complete picture of the costs, benefits, feasibility, and sustainability of an SBI program within an EAP. ..
- Innovative Approaches to Modeling Alcohol RelapseG Marlatt; Fiscal Year: 2004..The abundance of treatment outcome data for addictive behaviors makes the proposed research an important and cost-effective contribution to the advancement of our understanding of the relapse process. ..
- Cognitive Behavioral Treatment of PTSD in SMI ClientsKim T Mueser; Fiscal Year: 2010..The results of this research will bring the field one step closer to having an evidence-based practice for trauma and PTSD in clients with SMI. ..
- Effectiveness of Alcohol Interventions Among TB Patients in Tomsk, RussiaSonya Shin; Fiscal Year: 2008..Finally, we have a diverse interdisciplinary team that has been able to formulate an integrated biosocial and culturally-appropriate approach to treating AUDs in this population. [unreadable] [unreadable] [unreadable]..
- Research Center on Managed Care and Drug Abuse TreatmentConstance Horgan; Fiscal Year: 2008..This pilot will explore the feasibility for a large-scale study of the incremental impact of adding a substance abuse treatment parity benefit to private health insurance in California. ..
- NEUROTROPHINS AND REPEATED COCAINERobert Pierce; Fiscal Year: 2002....
- Colorectal Cancer Screening in Primary Care PracticeSteven Ornstein; Fiscal Year: 2009..A mixed-method process evaluation will also be conducted to assess the adoption of PPRNet-TRIP within participating practices. ..
- FACTORS AFFECTING USE OF MEDICATION TO TREAT ALCOHOLISMTAMI MARK; Fiscal Year: 2001..We propose to collect this information through experts panels and a national survey of physicians specialized in treating substance abuse. ..
- INTERVENTION FOR ADOLESCENT INDIAN DRINKINGG Marlatt; Fiscal Year: 2001..115 outpatients and 80 continuing care patients will participate in each of the two treatment conditions. ..
- CBT and Modafinil for Cocaine AddictionRobert Malcolm; Fiscal Year: 2009....
- Neurobehavioral Assessment of Ethanol Seeking and IntakeCristine Czachowski; Fiscal Year: 2005....
- Efficacy of Mindfulness-Based Relapse PreventionG Marlatt; Fiscal Year: 2007..unreadable] [unreadable]..
- Home Base Treatment for Drug Use in Early AdolescentsOscar Bukstein; Fiscal Year: 2005..These interventions are expected to improve not only substance abuse outcomes, but a range of impairments and symptoms associated with the DBDs and high risk for the early onset type of substance use disorder. ..
- Adoption of Pharmacotherapy in Alcoholism TreatmentPeter Miller; Fiscal Year: 2005..abstract_text> ..
- Form/function of Extended Amygdala/Accumbens Shell:CRFDANIEL ZAHM; Fiscal Year: 2005....
- FAMILY INTERVENTION FOR SMI AND SUBSTANCE USE DISORDERSKim Mueser; Fiscal Year: 2005..Improvements in these areas may the have long-term benefit of maintaining family involvement with dually diagnosed clients, thereby reducing housing instability and homelessness. ..
- Potential anti-relapse drugs: a plant genomics approachJohn Littleton; Fiscal Year: 2004..In phase 3, potential products will be commercialized with a partner specializing in pharmaceutical natural products. ..
- PHARMACOLOGICAL AND BEHAVIORAL TREATMENT WITH ALCOHOLICSDennis Donovan; Fiscal Year: 2004..However, each study site has provided site-specific information on the budget, budget justifications, listing of key personnel, consultant/consortium agreements, and human subjects sections of their respective proposals. ..
- Increasing Treatment Adherence in Co-Occurring DisordersMichael Pantalon; Fiscal Year: 2006..Secondary outcomes include reductions in depressive symptomatology and rates of re-hospitalization. ..
- MEDICATION/PSYCHOTHERAPY TAILORED TO PATIENT RESOURCESRobert Swift; Fiscal Year: 2004..However, each study site has provided site-specific information on the budget, budget justifications, listing of key personnel, consultant/consortium agreements, and human subjects sections of their respective proposals. ..
- LPH to VTA Neurotensin: Actions and Cocaine EffectsDANIEL ZAHM; Fiscal Year: 2004..The data may lead to better, more selective therapeutic approaches to prevention of psychostimulant sensitization, which is thought play a significant role in destructive drug seeking behaviors. ..
- Device for Acamprosate Transcutaneous Delivery to Reduce Alcohol Consumption.Robert Swift; Fiscal Year: 2006..unreadable] [unreadable] [unreadable]..
- Novel estrogen receptor ligands from plant genomicsJohn Littleton; Fiscal Year: 2006..unreadable] [unreadable] [unreadable]..
- Clinical-Genetic Variation in GABA /Alcohol SensitivityJohn Roache; Fiscal Year: 2004....
- Facilitating Alcohol Screening of Hypertensive PatientsPeter Miller; Fiscal Year: 2006..Such screening and intervention should improve blood pressure control in many of these patients and, in turn, reduce risk of chronic disease and death. ..
- Gabapentin for Cannabis Withdrawal and UseBarbara Mason; Fiscal Year: 2007..unreadable] [unreadable]..
- Application of plant genomics to alcoholic brain damageJohn Littleton; Fiscal Year: 2006..unreadable] [unreadable]..
- DEVELOPMENT OF SCREENS FOR DRUGS IN ALCOHOL DEPENDENCEJohn Littleton; Fiscal Year: 2007..abstract_text> ..
- Alcohol Phenotype Development in American SamoaRobert Swift; Fiscal Year: 2008..We will also utilize behavioral testing [unreadable] to assess the potential endophenotypes of sweet preference, risk taking, and cue-induced alcohol craving in the participants. [unreadable] [unreadable] [unreadable]..